340B Prioritizes Profits

A recent report on 340B hospitals and pharmacies in Minnesota reveals that covered entities continue to profit off of the program while leaving patients behind. Reported 340B revenue more than doubled between 2023 and 2024, but the quality of care and availability of medicine stayed the same. This revenue is being used to pad the pockets of big healthcare networks and out-of-state contract pharmacies. Disproportionate Share Hospitals, or hospitals that treat large numbers of un-or-underinsured patients, profit off this system most, accounting for 80% of all 340B revenue. 340B revenue covers internal and external hospital costs but is rarely used to improve patient experience or lower the cost of medicine. Our Health Equity advocates for large scale reforms to the 340B program that ensure patients have access to the medicine they need at a reasonable price. Read the full report here.